Vicarious Surgical Inc. (RBOT) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Vicarious Surgical Inc. (RBOT) stock forecast summary
On Oct. 13, 2026, RBOT is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.
Vicarious Surgical Inc. is a small-cap company with a market capitalization of $360K. It ranks number 24 by market capitalization among the 24 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast. Its ROE of -509.9% is the lowest of the 20 peers that report one.
A per-ticker accuracy statistic for RBOT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, RBOT included.
Follow RBOT freeRBOT price chart and AI forecast
How RBOT ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Vicarious Surgical Inc. (RBOT) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
Valuation & Market
| Metric | RBOT | Rank |
|---|---|---|
| Market Cap | $360K | 24/24 |
Profitability & Margins
| Metric | RBOT | Rank |
|---|---|---|
| ROE | -509.9% | 20/20 |
| ROA | -256.3% | 20/20 |
Financial Health
| Metric | RBOT | Rank |
|---|---|---|
| Current Ratio | 2.97x | 10/24 |
| D/E Ratio | 0.99x | 8/23 |
| Financial Leverage | 1.99x | 8/23 |
| Interest Coverage | -3086.0x | 20/21 |
Dividend & Shareholder Information
| Metric | RBOT | Rank |
|---|---|---|
| Shares Outstanding | 7M | – |
RBOT quarterly financials and insider trading
Vicarious Surgical Inc. (RBOT) industry peers
Companies classified under the same SEC industry code as Vicarious Surgical Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| RBOT Vicarious Surgical Inc. | ▶ | $360K |
| ISRG Intuitive Surgical Inc | ▼ | $149.10B |
| SNN Smith & Nephew Plc | ▼ | $24.45B |
| STE Steris Plc | ▼ | $21.23B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $17.56B |
| ALGN Align Technology Inc | ▶ | $10.20B |
| MSA Msa Safety Inc | ▼ | $7.01B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.74B |
| CDRE Cadre Holdings, Inc. | ▲ | $1.12B |
| ENOV Enovis Corp | ▶ | $1.10B |
| AVR Anteris Technologies Global Corp. | ▼ | $629M |
| SMTI Sanara Medtech Inc. | ▼ | $323M |
| INGN Inogen Inc | ▶ | $168M |
| LAKE Lakeland Industries Inc | ▲ | $97M |
| NTRB Nutriband Inc. | ▲ | $71M |
| APT Alpha Pro Tech Ltd | ▲ | $59M |
| MYO Myomo, Inc. | ▲ | $51M |
| COCH Envoy Medical, Inc. | ▶ | $51M |
| MLSS Milestone Scientific Inc. | ▲ | $30M |
| LFWD Lifeward Ltd. | ▲ | $18M |
| UEEC United Health Products, Inc. | ▶ | $12M |
| RGNT Regentis Biomaterials Ltd. | ▶ | $8M |
| CLGN Collplant Biotechnologies Ltd | ▲ | $5M |
| FEED Envue Medical, Inc. | ▼ | $510K |
| BBLG Bone Biologics Corp | ▲ | N/A |
| CUPR Cuprina Holdings (Cayman) Ltd | ▼ | N/A |
| LGMK Logicmark, Inc. | ▼ | N/A |
Where RBOT sits on the market map
Vicarious Surgical Inc. (RBOT) stock news
Loading...
Vicarious Surgical Inc. (RBOT) stock forecast FAQ
What is the Vicarious Surgical Inc. (RBOT) stock forecast?
On Oct. 13, 2026, RBOT is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.
How accurate are Vicarious Surgical Inc. stock predictions?
A per-ticker accuracy statistic for RBOT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Vicarious Surgical Inc. forecasts updated?
Vicarious Surgical Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Vicarious Surgical Inc.'s industry peers?
27 issuers in our coverage, RBOT included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.